Cargando…
HSD17B13: A Potential Therapeutic Target for NAFLD
Nonalcoholic fatty liver disease (NAFLD), especially in its inflammatory form (steatohepatitis, NASH), is closely related to the pathogenesis of chronic liver disease. Despite substantial advances in the management of NAFLD/NASH in recent years, there are currently no efficacious therapies for its t...
Autores principales: | Zhang, Hai-bo, Su, Wen, Xu, Hu, Zhang, Xiao-yan, Guan, You-fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776652/ https://www.ncbi.nlm.nih.gov/pubmed/35071330 http://dx.doi.org/10.3389/fmolb.2021.824776 |
Ejemplares similares
-
Cellular heterogeneity and plasticity during NAFLD progression
por: Park, Hyun-Ju, et al.
Publicado: (2023) -
Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis
por: Zhao, Xin, et al.
Publicado: (2022) -
The role of bile acid metabolism in the occurrence and development of NAFLD
por: Bing, Hao, et al.
Publicado: (2022) -
Hsp70 Is a Potential Therapeutic Target for Echovirus 9 Infection
por: Wang, Yang, et al.
Publicado: (2020) -
TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets
por: Zhang, Cheng, et al.
Publicado: (2022)